Article info

Download PDFPDF
Serous carcinoma of the uterus—determination of HER-2/neu status using immunohistochemistry, chromogenic in situ hybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation

Authors

  1. Address correspondence and reprint requests to: Piksi Singh, MD, Department of Gynaecology Oncology, Royal Adelaide Hospital, North Terrace-5000, Adelaide, South Australia. Email: drpiksi{at}hotmail.com

Citation

Singh P, Smith CL, Cheetham G, et al
Serous carcinoma of the uterus—determination of HER-2/neu status using immunohistochemistry, chromogenic in situ hybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation

Publication history

  • First published October 1, 2008.
Online issue publication 
March 06, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.